Literature DB >> 33307172

Acute neuroinflammation, sickness behavior and working memory responses to acute systemic LPS challenge following noradrenergic lesion in mice.

Eoin O'Neill1, Éadaoin W Griffin2, Ruairi O'Sullivan2, Carol Murray2, Lucy Ryan2, Justin Yssel3, Andrew Harkin4, Colm Cunningham5.   

Abstract

Locus coeruleus (LC)-derived noradrenaline is important in cognition and decreases with age, but the impact of prior noradrenaline deficiency on vulnerability to inflammation-induced acute cognitive dysfunction is unclear. Here we assessed whether noradrenergic depletion, in female mice, impacted upon inflammation, locomotor activity and working memory directly after acute systemic immune challenge with bacterial lipopolysaccharide (LPS), a paradigm we have previously used to capture delirium-like acute cognitive deficits. Mice received 2 doses of the LC-selective noradrenergic toxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4; 50 mg/kg i.p.) and were challenged, 2 weeks later, with LPS (100 μg/kg i.p.). DSP-4 dramatically reduced noradrenaline concentrations and tyrosine hydroxylase-positive afferents in the frontal cortex and hippocampus. This did not significantly alter numbers of Pu.1-positive microglia, Iba1-positive microglial morphology or mRNA expression of microglia-associated gene transcripts (Tyrobp, Sall1, Cd68, Sra2, Clec7a) in the hippocampus or frontal cortex and produced modest reductions in Cx3cr1 and P2ry12. LPS induced blood and brain cytokine levels, cFOS activation and locomotor responses that were highly similar in DSP-4- and vehicle-treated mice, although LPS-induced plasma TNF-α was significantly reduced in those treated with DSP-4. Importantly, prior noradrenergic depletion did not predispose to LPS-induced T-maze working memory deficits. The data demonstrate that significant depletion of noradrenaline in the hippocampus and frontal cortex does not prompt acutely exaggerated neuroinflammation or leave the brain vulnerable to acute, transient working memory deficits upon low dose LPS challenge. These findings have implications for our understanding of the impact of systemic inflammation on the aging and vulnerable brain during septic encephalopathy and delirium.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Delirium; Inflammation; Microglia; Noradrenaline; Working memory

Year:  2020        PMID: 33307172     DOI: 10.1016/j.bbi.2020.12.002

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  5 in total

1.  Establishment of inflammatory model induced by Pseudorabies virus infection in mice.

Authors:  Chun Zhi Ren; Wen Yue Hu; Jin Wu Zhang; Ying Yi Wei; Mei Ling Yu; Ting Jun Hu
Journal:  J Vet Sci       Date:  2021-03       Impact factor: 1.672

2.  A Noradrenergic Lesion Attenuates Surgery-Induced Cognitive Impairment in Rats by Suppressing Neuroinflammation.

Authors:  Jiayu Wang; Ying Zhou; Ke Li; Xiaofeng Li; Meimei Guo; Mian Peng
Journal:  Front Mol Neurosci       Date:  2021-11-30       Impact factor: 5.639

3.  Monophosphoryl Lipid A Tolerance Against Chronic Stress-Induced Depression-Like Behaviors in Mice.

Authors:  Fu Li; Xu Lu; Yaoying Ma; Yue Gu; Ting Ye; Chao Huang
Journal:  Int J Neuropsychopharmacol       Date:  2022-05-27       Impact factor: 5.678

4.  Dexmedetomidine Ameliorated Cognitive Dysfunction Induced by Intestinal Ischemia Reperfusion in Mice with Possible Relation to the Anti-inflammatory Effect Through the Locus Coeruleus Norepinephrine System.

Authors:  Gang Li; Jun Zhou; Jicheng Wei; Bin Liu
Journal:  Neurochem Res       Date:  2022-08-09       Impact factor: 4.414

5.  Identifying the Involvement of Pro-Inflammatory Signal in Hippocampal Gene Expression Changes after Experimental Ischemia: Transcriptome-Wide Analysis.

Authors:  Galina T Shishkina; Natalia V Gulyaeva; Dmitriy A Lanshakov; Tatyana S Kalinina; Mikhail V Onufriev; Yulia V Moiseeva; Ekaterina V Sukhareva; Vladimir N Babenko; Nikolay N Dygalo
Journal:  Biomedicines       Date:  2021-12-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.